Skip to main content

Barrett Esophagus

Hightower’s teams worked tirelessly for a treatment for Barrett’s esophagus that could help individuals.

                       

Know About Barrett's Esophagus Research Study

Barrett’s esophagus develops when the lining of the esophagus undergoes abnormal healing, transitioning from skin-like cells to cells resembling those found in the intestine. It is often a result of long-standing gastroesophageal reflux disease (GERD). Barrett’s esophagus can increase the risk of developing cancer.

Hightower Clinical conducted research on an investigational device to assess its effectiveness in screening for Barrett’s esophagus (BE) and esophageal adenocarcinoma (EAC) in high-risk patients. The study compared the investigational device’s performance with the screening method.

Current Status

Not Recruiting

Study Count

1

Frequently Asked Questions

Can Barrett's esophagus lead to cancer?

While Barrett’s esophagus itself does not cause symptoms, it can increase the risk of developing esophageal adenocarcinoma (EAC), a type of cancer.

What are the common symptoms of Barrett's esophagus?

Barrett’s esophagus typically does not cause noticeable symptoms. However, individuals may experience symptoms associated with gastroesophageal reflux disease (GERD), such as heartburn, regurgitation, chest pain, and difficulty swallowing.

Will I be compensated for participating in a clinical trial?

Some trials offer compensation for time and travel, but this varies depending on the study.

Is my information kept confidential during a clinical trial?

Yes, all clinical trials have strict privacy protocols to protect your personal information.